FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gilbert Block

Research Profile

Chemicals & Drugs

Procedures

Disorders

Concepts & Ideas

Neuropsychological Tests

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Leon J Thal; Steven H Ferris; Louis Kirby; Gilbert A Block; Christopher R Lines; Eric Yuen; Chris Assaid; Michael L Nessly; Barbara A Norman; Christine C Baranak; Scott A Reines
A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment.
Scott A Reines; Gilbert A Block; John C Morris; G Liu; Michael L Nessly; Christopher R Lines; B A Norman; C C Baranak
Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study.
Christopher R Lines; Kathleen McCarroll; richard lipton; Gilbert A Block
Telephone screening for amnestic mild cognitive impairment.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gilbert Block (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: Leon J Thal; Steven H Ferris; Louis Kirby; Gilbert A Block; Christopher R Lines; Eric Yuen; Chris Assaid; Michael L Nessly; Barbara A Norman; Christine C Baranak; Scott A Reines
A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2005;30(6):1204-15.
2004: Scott A Reines; Gilbert A Block; John C Morris; G Liu; Michael L Nessly; Christopher R Lines; B A Norman; C C Baranak
Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study.
Neurology 2004;62(1):66-71.
2003: Christopher R Lines; Kathleen McCarroll; richard lipton; Gilbert A Block
Telephone screening for amnestic mild cognitive impairment.
Neurology 2003;60(2):261-6.
1999: Suzanne Ahrens; M V Farmer; D L Williams; E Willoughby; K Jiang; Gilbert A Block; W Hester Visser
Efficacy and safety of rizatriptan wafer for the acute treatment of migraine. Rizatriptan Wafer Protocol 049 Study Group.
Cephalalgia : an international journal of headache 1999;19(5):525-30.
1999: G M Davies; Nancy C Santanello; W Gerth; D Lerner; Gilbert A Block
Validation of a migraine work and productivity loss questionnaire for use in migraine studies.
Cephalalgia : an international journal of headache 1999;19(5):497-502.
1998: Gilbert A Block; J Goldstein; Adam B Polis; Scott A Reines; M E Smith
Efficacy and safety of rizatriptan versus standard care during long-term treatment for migraine. Rizatriptan Multicenter Study Groups.
Headache 1998;38(10):764-71.
1998: Peer Tfelt-Hansen; J Teall; F Rodriguez; M Giacovazzo; J Paz; William Malbecq; Gilbert A Block; Scott A Reines; W Hester Visser
Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group.
Headache 1998;38(10):748-55.
1995: John J Sramek; Gilbert A Block; Scott A Reines; S F Sawin; A Barchowsky; Neal R Cutler
A multiple-dose safety trial of eptastigmine in Alzheimer's disease, with pharmacodynamic observations of red blood cell cholinesterase.
Life sciences 1995;56(5):319-26.
1993: Neal R Cutler; John J Sramek; Gilbert A Block
Poor tolerability of MK-458.
Archives of neurology 1993;50(9):896.